Cogent Biosciences, Inc. Ratios

Ratios Dec2017 Dec2018 Dec2019 Dec2020
Profitability
EBT Margin -308.21%-358.04%-141.83%-1,042.50%
EBIT Margin -312.82%-369.89%-143.02%-1,044.33%
EBITDA Margin -304.83%-354.72%-141.43%-950.43%
Operating Margin -312.82%-369.89%-143.02%-1,044.33%
Net Margin -305.71%-354.92%-141.49%-1,042.50%
FCF Margin -319.94%-339.41%-184.66%-455.47%
Efficiency
Assets Average 67.52M67.67M150.17M
Equity Average 5.69M46.00M133.21M
Invested Capital -48.85M60.23M31.76M234.67M
Asset Utilization Ratio 0.140.330.05
Leverage & Solvency
Equity Ratio -0.990.700.640.94
Valuation
Enterprise Value -49.58M34.01M-15.34M-114.81M
Market Capitalization 131.95M22.08M127.38M
Return Ratios
Return on Sales -3.08%-3.58%-1.42%-10.42%
Return on Capital Employed -0.85%-0.59%-0.60%
Return on Assets -0.52%-0.47%-0.55%
Return on Equity -6.12%-0.69%-0.62%